Miguel Sagues Serrano
Overview
    Explore the profile of Miguel Sagues Serrano including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              6
            
            
              Citations
              88
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Barbui T, Carobbio A, Ghirardi A, Iurlo A, De Stefano V, Sobas M, et al.
  
  
    Blood Cancer J
    . 2022 Nov;
          12(11):154.
    
    PMID: 36379921
  
  
          No abstract available.
      
2.
        
    
    Barbui T, Carobbio A, Ghirardi A, Iurlo A, Sobas M, Elli E, et al.
  
  
    Am J Hematol
    . 2022 Sep;
          97(12):E470-E473.
    
    PMID: 36111658
  
  
          No abstract available.
      
3.
        
    
    Barbui T, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Carioli G, et al.
  
  
    Leukemia
    . 2022 Jan;
          36(3):897-900.
    
    PMID: 35064223
  
  
          No abstract available.
      
4.
        
    
    Barbui T, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Rossi G, et al.
  
  
    Blood Cancer J
    . 2021 Jun;
          11(6):115.
    
    PMID: 34135309
  
  
          No abstract available.
      
5.
        
    
    Barbui T, De Stefano V, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, et al.
  
  
    Blood Cancer J
    . 2021 Feb;
          11(2):21.
    
    PMID: 33563901
  
  
          In a multicenter European retrospective study including 162 patients with COVID-19 occurring in essential thrombocythemia (ET, n = 48), polycythemia vera (PV, n = 42), myelofibrosis (MF, n = 56),...
      
6.
        
    
    Barbui T, Vannucchi A, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, et al.
  
  
    Leukemia
    . 2021 Jan;
          35(2):485-493.
    
    PMID: 33414483
  
  
          We report the clinical presentation and risk factors for survival in 175 patients with myeloproliferative neoplasms (MPN) and COVID-19, diagnosed between February and June 2020. After a median follow-up of...